Work

Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.3_suppl.168

Authors: Ibrahim Halil Sahin, Joanne Xiu, Moh'd M. Khushman, Emily Palumbo, Benjamin Adam Weinberg, Mehmet Akce, Aatur D. Singhi, Phoenix D. Bell, Anup Kasi, Anthony F. Shields, Matthew James Oberley, George W. Sledge, John Paul Y.C. Shen, Anwaar Saeed, Mohamedtaki Abdulaziz Tejani

Institutions: University of Pittsburgh Medical Center, Caris Life Sciences (United States), Washington University in St. Louis, Georgetown Lombardi Comprehensive Cancer Center, University of Alabama at Birmingham, University of Pittsburgh, The University of Kansas Cancer Center, The Barbara Ann Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, AdventHealth Orlando, AdventHealth

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391095945

Cites:

Cited by: 1

Related to: 10